Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Positive phase I results for Prima BioMed's dendritic cell-based therapy

Oct. 28, 2002

Novel antiproliferative agents prepared at Temple University

Oct. 25, 2002

Clofarabine enters phase I/II trial in combination with ara-C

Oct. 25, 2002

CYP1B1-activated prodrugs of antitumor compound identified by U. of London researchers

Oct. 25, 2002

AstraZeneca presents novel GnRH antagonists for cancer, BPH and uterine myoma

Oct. 25, 2002

Epothilones: multimedia presentation of mechanisms of action in Part II of an Integrity Case Study

Oct. 25, 2002

Enact reports titanium-based organometallic compounds as anticancer agents

Oct. 25, 2002

diaDexus and Emory University form cancer collaboration to target Nox-1 enzyme

Oct. 25, 2002

Combination of gene therapy + irradiation shows promise in prostate cancer model

Oct. 24, 2002

Novel JNK inhibitors prepared and tested at Signal

Oct. 24, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...